Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baozhu Granule as a Novel Treatment Strategy for Diminished Ovarian Reserve: A Prospective Clinical Trial.

Rejuvenation research·2026
Same author

Reply to Takada and Komine-Aizawa, "Bacterial vaginosis and the gut-vagina axis".

Microbiology spectrum·2026
Same author

Ovarian Matrisome Dynamics and αvβ3-Mediated Regulation in Early Follicular Development.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Carbon-based nanomaterials induce ovarian dysfunction via NLRP3 inflammasome-mediated pyroptosis in granulosa cells.

Journal of advanced research·2026
Same author

FSHR-targeting tetrahedral DNA frameworks ameliorate ovarian aging through oxidative stress elimination.

Journal of nanobiotechnology·2026
Same author

Mitochondrial Unfolded Protein Responsive Imaging and Surgical Navigation in Ovarian Cancer.

Chemical & biomedical imaging·2025

Related Experiment Video

Updated: Jul 4, 2026

Production and Use of Customizable Agarose Molds for Scaffold-Free Mouse Ovarian Follicle Culture
09:50

Production and Use of Customizable Agarose Molds for Scaffold-Free Mouse Ovarian Follicle Culture

Published on: October 24, 2025

Modulating IL-11-dependent matrix stiffness to delay ovarian aging.

Meng Wu1,2,3, Qingqing Zhu1,2,3, Jiaqiang Xiong4

  • 1Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Nature Aging
|July 2, 2026
PubMed
Summary
This summary is machine-generated.

Ovarian matrix stiffening, linked to aging and disease, is caused by elevated IL-11 activating fibroblasts. Blocking IL-11 signaling in mice improved ovarian function and reduced stiffness, suggesting anti-IL-11 therapy for ovarian aging.

More Related Videos

Orthotopic Ovarian Transplantation Procedures to Investigate the Life- and Health-span Influence of Ovarian Senescence in Female Mice
06:49

Orthotopic Ovarian Transplantation Procedures to Investigate the Life- and Health-span Influence of Ovarian Senescence in Female Mice

Published on: February 12, 2018

Related Experiment Videos

Last Updated: Jul 4, 2026

Production and Use of Customizable Agarose Molds for Scaffold-Free Mouse Ovarian Follicle Culture
09:50

Production and Use of Customizable Agarose Molds for Scaffold-Free Mouse Ovarian Follicle Culture

Published on: October 24, 2025

Orthotopic Ovarian Transplantation Procedures to Investigate the Life- and Health-span Influence of Ovarian Senescence in Female Mice
06:49

Orthotopic Ovarian Transplantation Procedures to Investigate the Life- and Health-span Influence of Ovarian Senescence in Female Mice

Published on: February 12, 2018

Area of Science:

  • Reproductive biology
  • Biomaterials science
  • Cellular biology

Background:

  • Ovarian mechanical properties are vital for function.
  • Mechanisms of age-related ovarian matrix stiffening are not fully understood.
  • Ovarian stiffening is associated with aging and conditions like POI, PCOS, and endometriosis.

Purpose of the Study:

  • To investigate the mechanisms driving ovarian matrix stiffening with aging and disease.
  • To identify molecular factors regulating ovarian stiffness.
  • To explore therapeutic strategies targeting ovarian aging.

Main Methods:

  • Atomic force microscopy (AFM) to measure ovarian matrix stiffness.
  • Proteomic and transcriptomic analyses of human ovarian tissue and fibroblasts.
  • Genetic manipulation (Il11ra1 deletion) and nanoparticle-based gene silencing (siIl11) in mouse models.
  • Single-nuclei RNA sequencing (snRNA-seq) to analyze fibroblast activation.

Main Results:

  • Ovarian matrix stiffness increases with aging and in POI, PCOS, and endometriosis.
  • Elevated IL-11 activates fibroblasts to increase extracellular matrix (ECM) production and stiffness.
  • Blocking IL-11 signaling (Il11ra1 deletion) mitigated stiffness and improved ovarian function in aging and disease models.
  • siIl11 nanoparticle administration enhanced fertility and reduced stiffness in aged rodents.

Conclusions:

  • IL-11 is a key regulator of ovarian matrix stiffness.
  • Targeting IL-11 signaling offers a potential therapeutic approach to delay ovarian aging and improve reproductive outcomes.